Accelerant Take-Private With Thoma Bravo
Accelerant take-private agreed Aug. 13, 2026 with Thoma Bravo paying $20.25 a share, narrowing financing risk and focusing traders on regulatory timing.
KEY TAKEAWAYS
- All-cash deal at $20.25 per share valuing the company at more than $4.0 billion.
- Agreement is not subject to any financing condition due to Thoma Bravo equity commitment, reducing arbitrage risk.
- Altamont-affiliated holders control about 82.0% of voting rights, lowering shareholder-approval risk.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
Accelerant Holdings agreed on Aug. 13, 2026, to be acquired by Thoma Bravo in a take-private transaction and issued second-quarter 2026 results the same day, a combination that lifted its shares as the deal advances toward closing.
Deal Terms, Governance, and Results
Accelerant entered a definitive agreement to be acquired by Thoma Bravo in an all-cash deal valuing the company at more than $4.0 billion. Holders of Class A and Class B shares will receive $20.25 per share, a 49.0% premium to the Aug. 12 closing price. The special independent committee unanimously recommended the transaction, and the board approved it. The agreement is not subject to any financing condition, as Thoma Bravo provided an equity commitment to fund the purchase, reducing principal arbitrage risk and supporting a prompt closing.
The transaction is expected to close in the first half of 2027. Upon completion, Accelerant’s common shares will be delisted from the New York Stock Exchange. If closing is delayed due to pending insurance regulatory approvals, shareholders will receive a 6.0% per annum ticking fee for a defined period.
Entities affiliated with Altamont Capital Partners, which control about 82% of voting rights, agreed to vote their shares in favor of the deal, significantly lowering shareholder-approval risk. Accelerant issued its second-quarter 2026 results via Business Wire on Aug. 13, 2026, at 7:24 a.m. ET. Third-party coverage described the results as stronger than expected, contributing to investor interest alongside the buyout terms.
The equity commitment and substantial voting support reduce financing and shareholder-vote risks, while required insurance and other regulatory approvals remain the primary uncertainties affecting the transaction’s timing and execution.
